Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predicting short-term treatment toxicity in head and neck cancer through a systematic review and meta-analysis.
Mascarella MA, Vendra V, Sultanem K, Tsien C, Shenouda G, Sridharan S, Bouganim N, Esfahani K, Richardson K, Mlynarek A, Hier M, Sadeghi N, Duvvuri U, Kergoat MJ. Mascarella MA, et al. Among authors: vendra v. J Geriatr Oncol. 2024 Nov;15(8):102064. doi: 10.1016/j.jgo.2024.102064. Epub 2024 Sep 13. J Geriatr Oncol. 2024. PMID: 39271411 Free article.
Sarcopenia predicts short-term treatment-related toxicity in patients undergoing curative-intent therapy for head and neck cancer: A systematic review and meta-analysis.
Mascarella MA, Ferdus J, Vendra V, Sridharan S, Sultanem K, Tsien C, Shenouda G, Bouganim N, Esfahani K, Richardson K, Mlynarek A, Sadeghi N, Hier M, Kergoat MJ. Mascarella MA, et al. Among authors: vendra v. Head Neck. 2024 Jun;46(6):1500-1509. doi: 10.1002/hed.27688. Epub 2024 Feb 14. Head Neck. 2024. PMID: 38353170 Review.
Oncologic Safety of Close Margins in Patients With Low- to Intermediate-Grade Major Salivary Gland Carcinoma.
Sajisevi M, Nguyen K, Callas P, Holcomb AJ, Vural E, Davis KP, Thomas CM, Plonowska-Hirschfeld KA, Stein JS, Eskander A, Kakarala K, Enepekides DJ, Hier MP, Ryan WR; American Head and Neck Society Salivary Gland Section; Asarkar AA, Aulet R, Bell RK, Blasco MA, Bowmaster VB, Burruss CP, Chung J, Chan K, Chang BA, Coffey CS, Cognetti DM, Cooper DJ, Cordero J, Donovan J, Du YJ, Dundar Y, Dedivitis RA, Edwards HA, Erovic BM, Feinberg PA, Garvey EA, Goldstein DP, Goodman JF, Goulart RN, Goyal N, Grasl S, Giurintano JP, Gupta N, Habib AM, Hackman TG, Hara JH, Henson C, Hinni ML, Hua N, Johnson-Obaseki S, Juloori A, Kalman NS, Kejner AE, Khaja SF, Ku JA, Lambert A, Luu BK, Magliocca KR, Dos Santos LRM, Michael C, Miles BA, de Melo GM, Moore MG, Morand GB, Moura K, Mukdad L, Noroozi H, Patel R, Paydarfar JA, Sadeghi N, Savaria FN, Schmitt NC, Shapiro J, Shaver TB, Stoeckli SJ, St John M, Stokes WA, Sulibhavi A, Tasoulas J, Vendra V, Vinh DB, Virgen CG, Wooten C, Woody NM, Young GD. Sajisevi M, et al. Among authors: vendra v. JAMA Otolaryngol Head Neck Surg. 2024 Feb 1;150(2):107-116. doi: 10.1001/jamaoto.2023.3952. JAMA Otolaryngol Head Neck Surg. 2024. PMID: 38095911 Free PMC article.
Response to Neoadjuvant Targeted Therapy in Operable Head and Neck Cancer Confers Survival Benefit.
Mascarella MA, Olonisakin TF, Rumde P, Vendra V, Nance MA, Kim S, Kubik MW, Sridharan SS, Ferris RL, Fenton MJ, Clayburgh DR, Ohr JP, Joyce SC, Sen M, Herman JG, Grandis JR, Zandberg DP, Duvvuri U. Mascarella MA, et al. Among authors: vendra v. Clin Cancer Res. 2023 Feb 16;29(4):723-730. doi: 10.1158/1078-0432.CCR-22-1768. Clin Cancer Res. 2023. PMID: 36595540 Free PMC article.
Poor treatment tolerance in head and neck cancer patients with low muscle mass.
Mascarella MA, Patel T, Vendra V, Gardiner L, Kergoat MJ, Kubik MW, Solari MG, Snyderman CH, Traylor KS, Ferris RL, Kim S, Duvvuri U, Sridharan SS. Mascarella MA, et al. Among authors: vendra v. Head Neck. 2022 Apr;44(4):844-850. doi: 10.1002/hed.26978. Epub 2022 Jan 12. Head Neck. 2022. PMID: 35020252 Free PMC article.
Cervical paraspinal skeletal muscle index outperforms frailty indices to predict postoperative adverse events in operable head and neck cancer with microvascular reconstruction.
Mascarella MA, Gardiner L, Patel T, Vendra V, Khan N, Kergoat MJ, Kubik MW, Solari MG, Snyderman CH, Traylor KS, Sridharan SS. Mascarella MA, et al. Among authors: vendra v. Microsurgery. 2022 Mar;42(3):209-216. doi: 10.1002/micr.30848. Epub 2021 Dec 21. Microsurgery. 2022. PMID: 34935198
26 results